Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / April / Endometriosis Blood Test An End to Years of Agony
Liquid biopsy Microbiology and Immunology Molecular Pathology Research and Innovations

Endometriosis Blood Test: An End to Years of Agony?

Multi-omic assay could reduce reliance on surgery and imaging

04/09/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Share

Top Institutions in Gynecology and Reproductive Medicine

Leading institutions in this area combine expertise in gynecology, molecular diagnostics, and bioinformatics to develop multi-omic biomarker panels and machine learning models for endometriosis diagnosis. They leverage clinical cohorts, advanced molecular assays, and translational research to validate non-invasive diagnostic tools.

  • #1

    Mayo Clinic

    Rochester, MN

    Mayo Clinic is renowned for its integrated approach combining clinical care and translational research in endometriosis, including biomarker discovery and validation using advanced molecular techniques and machine learning.

    Key Differentiators

    • Gynecology
    • Reproductive Endocrinology
    • Molecular Diagnostics
  • #2

    Cleveland Clinic

    Cleveland, OH

    Cleveland Clinic has a strong focus on minimally invasive gynecologic surgery and molecular diagnostics, contributing to advances in non-invasive endometriosis detection and clinical implementation of biomarker assays.

    Key Differentiators

    • Gynecology
    • Minimally Invasive Surgery
    • Molecular Biology
  • #3

    University of California, San Francisco (UCSF)

    San Francisco, CA

    UCSF is a leader in reproductive health research with strong programs in endometriosis pathophysiology, biomarker discovery, and application of machine learning to clinical diagnostics.

    Key Differentiators

    • Gynecology
    • Reproductive Medicine
    • Bioinformatics
  • #4

    Brigham and Women's Hospital

    Boston, MA

    Brigham and Women's Hospital has a robust translational research program focused on endometriosis, combining clinical expertise with molecular biomarker research and advanced diagnostic assay development.

    Key Differentiators

    • Gynecology
    • Reproductive Endocrinology
    • Translational Research
  • #5

    MRC Centre for Reproductive Health, University of Edinburgh

    Edinburgh, Scotland

    The MRC Centre is internationally recognized for its research on endometriosis pathogenesis and biomarker discovery, including multi-omic approaches and validation of blood-based diagnostic tests.

    Key Differentiators

    • Reproductive Medicine
    • Molecular Biology
    • Clinical Research

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

A Light in the Darkness
Liquid biopsy
A Light in the Darkness

March 4, 2022

2 min read

Spectroscopic liquid biopsy testing – a new route to brain cancer diagnostics

Biomarkers: The Bigger Picture
Liquid biopsy
Biomarkers: The Bigger Picture

April 27, 2022

1 min read

To unlock patient care, pathologists must focus on molecular pathology and ensure efficiency and effectiveness to improve testing. With this testing, patients can benefit from the best treatment to combat their disease.

Benchmarking… Liquid Biopsy
Liquid biopsy
Benchmarking… Liquid Biopsy

May 13, 2022

1 min read

A look at the last five years of publishing on liquid biopsy

Does Your Blood Know You Have Cancer?
Liquid biopsy
Does Your Blood Know You Have Cancer?

July 25, 2022

2 min read

Detection and monitoring are crucial for melanoma outcomes – could a blood test revolutionize both?

Affiliations:

Specialties:

Areas of Expertise:

View Full Profile Follow
Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.